CONCORD HEALTHCARE GROUP CO., LTD.

美中嘉和医学技术发展集团股份有限公司

02453.HK

Provides oncology healthcare services in China through six self-owned medical institutions, including cancer hospitals, clinics and an imaging center, serving cancer patients, and sells and installs oncology-related medical equipment and software to hospitals. Holds 0.5% share of China's private oncology healthcare market (per F&S Report, 2022).

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Overlapping customers and suppliers
• Distribution model
• Government or SOE customers and tenders
• Pricing policy and price changes
• Particular sales arrangements
• Business changes and acquisitions
• Seasonality and cyclicality
• Reliance on the controlling shareholder
• Losses and path to profitability
• Net current liabilities or net liabilities
• Negative operating cash flow
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Preferred shares and fair-value liabilities
• Indebtedness, guarantees and other contingent obligations
• Non-IFRS measures and adjustments
• Non-recurring gains and losses
• Related-party transactions and balances